Long-term follow-up of patients with Philadelphia chromosome-positive chronic myeloid leukemia after stem cell mobilization under imatinib

被引：0
作者：
Kim, Theo D. [1 ]
Schwarz, Michaela [1 ]
Kreuzer, Karl-Anton [3 ]
Kaeda, Jaspal [1 ]
Movassaghi, Kamran [2 ]
Grille, Peggy [1 ]
Daniel, Peter T. [1 ]
Doerken, Bernd [1 ]
le Coutre, Philipp [1 ]
机构：
[1] Charite, Klin Hamatol & Onkol, Campus Virchow Klinikum, D-13353 Berlin, Germany
[2] Charite, Inst Transfus Med, Campus Virchow Klinikum, D-13353 Berlin, Germany
[3] Univ Cologne, Innere Med Klin 1, Cologne, Germany
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 03期
关键词：
COMPLETE CYTOGENETIC RESPONSE; BLOOD; MESYLATE; TRANSPLANTATION; FILGRASTIM; COLLECTION; REMISSION; CML;
D O I：
10.3109/10428194.2010.535932
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：517 / 520
页数：4
相关论文
共 15 条
  • [1] Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
    Baccarani, Michele
    Cortes, Jorge
    Pane, Fabrizio
    Niederwieser, Dietger
    Saglio, Giuseppe
    Apperley, Jane
    Cervantes, Francisco
    Deininger, Michael
    Gratwohl, Alois
    Guilhot, Francois
    Hochhaus, Andreas
    Horowitz, Mary
    Hughes, Timothy
    Kantarjian, Hagop
    Larson, Richard
    Radich, Jerald
    Simonsson, Bengt
    Silver, Richard T.
    Goldman, John
    Hehlmann, Rudiger
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 6041 - 6051
  • [2] Imatinib for newly diagnosed patients with chronic myeloid leukemia: Incidence of sustained responses in an intention-to-treat analysis
    de Lavallade, Hugues
    Apperley, Jane F.
    Khorashad, Jamshid S.
    Milojkovic, Dragana
    Reid, Alistair G.
    Bua, Marco
    Szydlo, Richard
    Olavarria, Eduardo
    Kaeda, Jaspal
    Goldman, John M.
    Marin, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) : 3358 - 3363
  • [3] A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response
    Drummond, M. W.
    Heaney, N.
    Kaeda, J.
    Nicolini, F. E.
    Clark, R. E.
    Wilson, G.
    Shepherd, P.
    Tighe, J.
    McLintock, L.
    Hughes, T.
    Holyoake, T. L.
    [J]. LEUKEMIA, 2009, 23 (06) : 1199 - 1201
  • [4] Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission
    Drummond, MW
    Marin, D
    Clark, RE
    Byrne, JL
    Holyoake, TL
    Lennard, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (03) : 479 - 483
  • [5] Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products
    Gordon, Melinda K.
    Sher, Dorie
    Karrison, Theodore
    Kebriaei, Partow
    Chuang, Karen
    Zhang, Yanming
    Mcdonnell, Diane
    Artz, Andrew
    Godley, Lucy
    Odenike, Olatoyosi
    Rich, Elizabeth
    Michaelis, Laura
    Thirman, Michael J.
    Wickrema, Amittha
    Van Besien, Koen
    Larson, Richard A.
    Stock, Wendy
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (03) : 531 - 537
  • [6] Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
    Graham, SM
    Jorgensen, HG
    Allan, E
    Pearson, C
    Alcorn, MJ
    Richmond, L
    Holyoake, TL
    [J]. BLOOD, 2002, 99 (01) : 319 - 325
  • [7] Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
    Hochhaus, A.
    O'Brien, S. G.
    Guilhot, F.
    Druker, B. J.
    Branford, S.
    Foroni, L.
    Goldman, J. M.
    Mueller, M. C.
    Radich, J. P.
    Rudoltz, M.
    Mone, M.
    Gathmann, I.
    Hughes, T. P.
    Larson, R. A.
    [J]. LEUKEMIA, 2009, 23 (06) : 1054 - 1061
  • [8] Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR
    Hui, CH
    Goh, KY
    White, D
    Branford, S
    Grigg, A
    Seymour, JF
    Kwan, YL
    Walsh, S
    Hoyt, R
    Trickett, A
    Rudzki, B
    Ma, DDF
    To, LB
    Hughes, TP
    [J]. LEUKEMIA, 2003, 17 (05) : 821 - 828
  • [9] Survival benefit with imatinib mesylate versus interferon-α-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia
    Kantarjian, Hagop M.
    Talpaz, Moshe
    O'Brien, Susan
    Jones, Daniel
    Giles, Francis
    Garcia-Manero, Guillermo
    Faderl, Stefan
    Ravandi, Farhad
    Rios, Mary Beth
    Shan, Jianqin
    Cortes, Jorge
    [J]. BLOOD, 2006, 108 (06) : 1835 - 1840
  • [10] Kreuzer CA, 2003, HAEMATOLOGICA, V88, P1199
12